Overview


Michael W. Ryan advises manufacturers, health care providers, developers, and investors on the legal, regulatory, and reimbursement issues that arise during the development and commercialization of medical devices, drugs, biological products, and clinical laboratory testing services.

Show More

Results


  • Advised medical device manufacturers, clinical laboratories, and investors on evolving FDA regulatory paradigm for personalized medicine products
  • Engaged Center for Devices and Radiological Health leadership on issues related to proposed FDA oversight of LDTs

Show More

Community


  • American Health Lawyers Association
  • Food and Drug Law Institute

Credentials


Education
Wake Forest University School of Law, JD, magna cum laude, 2008
University of Maryland, BS, summa cum laude, 2003

Admissions
District of Columbia
Maryland

Michael W. Ryan

Insights & Events / Media

Speaking Engagements / November 4, 2019

Boston, Massachusetts / Speaking Engagements / September 22, 2019

Cambridge, MA / McDermott Event / March 20, 2019

Special Report / January 7, 2019

The Food and Drug Law Institute / July/August 2014

Work in Progress: FDA’s Regulation of Health Information Technology

1

2

3

4

5

6

7

8

9

10

... 10